FDA won petition to have ruling reconsidered

Share this article:
The FDA has won a petition to have the US Court of Appeals for the District of Columbia reconsider a ruling that mentally competent terminally ill patients should have access to post-Phase I investigational drugs if there are no government-approved alternatives.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.